Cargando…

Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019

Detalles Bibliográficos
Autores principales:	Kumar, Pramod, Kulkarni, Anand, Sharma, Mithun, Rao, Padaki Nagaraja, Reddy, Duvvuru Nageshwar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111097/ https://www.ncbi.nlm.nih.gov/pubmed/34007812 http://dx.doi.org/10.14218/JCTH.2021.00011

Ejemplares similares

Pathogenesis of Liver Injury in Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2–related Acute-on-chronic Liver Failure
por: Kumar, Pramod, et al.
Publicado: (2021)

Outcomes of Liver Transplant Recipients Infected with COVID-19 is Similar to Non- liver Transplant Patients
por: Kulkarni, Dr Anand V., et al.
Publicado: (2022)

COVID-19 Masquerading as Autoimmune Hepatitis (AIH) Flare—The First Report()
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis
por: Kulkarni, Anand V., et al.
Publicado: (2021)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
por: Sharma, Mithun, et al.
Publicado: (2021)

Exercise Caution with ChAdOx1 COVID-19 Vaccination in Chronic Budd-Chiari Syndrome with a Thrombophilic Genetic Predisposition
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects
por: Sharma, Mithun, et al.
Publicado: (2020)

Author Correction: Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects
por: Sharma, Mithun, et al.
Publicado: (2021)

COVID-19 vaccine induced autoimmune hepatitis-a first case series from India
por: Iyengar, Sowmya, et al.
Publicado: (2022)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
por: Jagdish, Rakesh Kumar, et al.
Publicado: (2023)

Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review
por: Kulkarni, Anand V, et al.
Publicado: (2020)

Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine
por: Kulkarni, Anand, et al.
Publicado: (2022)

Postliver Transplantation Rhino-Orbital Mucormycosis, an Unexpected Cause of a Downhill Course
por: Sabhapandit, Swapnali, et al.
Publicado: (2022)

Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities
por: Bale, Govardhan, et al.
Publicado: (2017)

Management of hepatitis B and C in special population
por: Kulkarni, Anand V, et al.
Publicado: (2021)

A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report
por: Patodiya, Bharat, et al.
Publicado: (2023)

Hairdye-Induced Hepatitis: An Unusal Cause of Acute Hepatitis
por: Gokak, Varadaraj P., et al.
Publicado: (2009)

Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time
por: Sharma, Mithun, et al.
Publicado: (2020)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

EUS-guided left lobe liver biopsy: Safer modality with similar diagnostic yield as right lobe: a pilot study
por: Sharma, Mithun, et al.
Publicado: (2023)

Predictors and Outcomes of Infections in ICU Patients With Cirrhosis: A Single-Center Observational Study
por: Kulkarni, Anand, et al.
Publicado: (2023)

Postcoronavirus disease-2019 symptoms are not uncommon among recovered patients: A cross-sectional online survey among the Indian population
por: Gella, Vishwanath, et al.
Publicado: (2022)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Srinivasan, Kritika, et al.
Publicado: (2021)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021)

Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel
por: Surapat, Bhitta, et al.
Publicado: (2022)

Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
por: Yevgi, Recep, et al.
Publicado: (2021)

Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
por: Chen, Ping-Jen, et al.
Publicado: (2021)

Rational Defensive Medicine: Putting an End to the Nationwide Favipiravir Debate
por: Öncel, Selim
Publicado: (2022)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
por: Takoi, Hiroyuki, et al.
Publicado: (2020)

Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019
por: Hase, Ryota, et al.
Publicado: (2020)

The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019
por: Çap, Murat, et al.
Publicado: (2020)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

An unusual case of bluish discoloration of the cornea after favipiravir therapy for COVID-19
por: Raiturcar, Tanvi P, et al.
Publicado: (2021)

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.
por: Mori, Nobuaki
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8va53tt38lbackpiobpn6cufga